10 July 2015

The theme of the 2015 ASCO (American Society of Clinical Oncology) Conference was: Illumination and Innovation - Transforming Data into Learning

"We are in an information age and there is a lot of data coming at us. We need to become smarter and more nimble about how we look at data and derive knowledge, and then that drives actual decision-making that improves patient outcomes."
- ASCO President Peter Yu, MD

Top 8 highlights from the 2015 ASCO Annual Meeting relevant for patients:

  1. Earlier chemotherapy may be better
  2. Neoadjuvant chemotherapy should be considered for localized high-risk prostate cancer patients
  3. New recommendations for castration-resistant prostate cancer clinical trial design and patient treatment
  4. New genomic classifier for lethal disease subset
  5. Stronger and earlier suppression of the androgen receptor may be better:
  6. Copy number gains or losses may mediate enzalutamide resistance:
  7. Distinguishing who should receive more therapy:
  8. A potential benefit for statins

To view the full report click here.